Welcome to our dedicated page for ZIMMER BIOMET HOLDINGS SEC filings (Ticker: ZBH), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Our SEC filing database is enhanced with expert analysis from Rhea-AI, providing insights into the potential impact of each filing on ZIMMER BIOMET HOLDINGS's stock performance. Each filing includes a concise AI-generated summary, sentiment and impact scores, and end-of-day stock performance data showing the actual market reaction. Navigate easily through different filing types including 10-K annual reports, 10-Q quarterly reports, 8-K current reports, proxy statements (DEF 14A), and Form 4 insider trading disclosures.
Designed for fundamental investors and regulatory compliance professionals, our page simplifies access to critical SEC filings. By combining real-time EDGAR feed updates, Rhea-AI's analytical insights, and historical stock performance data, we provide comprehensive visibility into ZIMMER BIOMET HOLDINGS's regulatory disclosures and financial reporting.
Zimmer Biomet Holdings has filed a Form S-8 to register securities under its 2009 Stock Incentive Plan. The company, a large accelerated filer headquartered in Warsaw, Indiana, is registering additional shares for employee benefits.
Key aspects of the filing include:
- Registration covers the amended and restated 2009 Stock Incentive Plan (referenced in 8-K filed June 3, 2025)
- Filing incorporates by reference several documents including the Annual Report for FY2024, Quarterly Report for Q1 2025, and proxy materials
- Includes comprehensive indemnification provisions for directors and officers under Delaware law
- Company maintains directors' and officers' liability insurance coverage
The filing includes standard undertakings regarding post-effective amendments and removal of unsold securities. Legal opinion and consent from PricewaterhouseCoopers LLP are filed as exhibits. This registration statement enables Zimmer Biomet to offer equity-based compensation to employees under its incentive plan.